Search
for
Sort by
Research 631–660 of 1000+
- The Functional Organization of Cutaneous Low-Threshold Mechanosensory Neurons
- Prevention of Male Late-Onset Hypogonadism by Natural Polyphenolic Antioxidants
- Role of Polyphenols in Dermatological Diseases: Exploring Pharmacotherapeutic Mechanisms and Clinical Implications
- Biliary fibrosis is an important but neglected pathological feature in hepatobiliary disorders: from molecular mechanisms to clinical implications
- Potential of Natural Products in Hangeshashinto Water Extract on the Direct Suppression of Stomatitis Induced by Intra-/Extracellular Advanced Glycation End-Products
- Application of multi-omics techniques to androgenetic alopecia: Current status and perspectives
- Ginseng and ginseng byproducts for skincare and skin health
- Transcriptomic analysis of regulatory mechanisms in the telogen-anagen transition of ovine hair follicles
- Modulating the Antioxidant Response for Better Oxidative Stress-Inducing Therapies: How to Take Advantage of Two Sides of the Same Medal?
- Erosive Pustular Dermatosis of the Scalp Due to Afatinib: A Rare Case
- Management of Toxicities of Targeted Therapies
- The Role of Cell Polarity Regulator aPKC in Hair Follicle Stem Cell Maintenance and Wound Healing
- Mucocutaneous Manifestations of Endocrine Disorders
- Topical treatment with the bacterium-derived c-Met agonist InlB321/15 accelerates healing in the abrasion wound mouse model
- Turning JAK STATic, a peek into the future of dermatology therapeutics
- Toxic Side Effects of Targeted Therapies and Immunotherapies Affecting the Skin, Oral Mucosa, Hair, and Nails
- 277 An open label pilot clinical trial of the JAK inhibitor tofacitinib for alopecia areata
- Small Molecule Inhibitors and Inflammatory Skin Diseases
- Mammalian Fetal Organ Regeneration
- Hair Depigmentation Is a Biological Readout for Pharmacological Inhibition of KIT in Mice and Humans
- Dermatologic Adverse Events from Cancer Treatments
- 皮膚組織の再生に向けた皮膚由来幹細胞に関する研究
- Neural Mechanisms of Hair Growth Control
- Rationale and Design of a Novel, Phase 3, External and Synthetic Placebo-Controlled Clinical Trial of Ritlecitinib 50 mg and 100 mg for Alopecia Areata
- Neonatal allopregnanolone or finasteride administration modifies hippocampal K+ Cl− co-transporter expression during early development in male rats
- Melanocytes: The new Black
- Spironolactone, a Classic Potassium-Sparing Diuretic, Reduces Survivin Expression and Chemosensitizes Cancer Cells to Non-DNA-Damaging Anticancer Drugs
- The pharmacovigilance analysis of adverse events of erlotinib based on the open access FAERS database
- ORAL TOFACITINIB IN MODERATE AND SEVERE ALOPECIA AREATA: CASE SERIES OF 14 PATIENTS
- Dermatologic Side Effects of Systemic Targeted Anticancer Therapy